Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

s_agr_2016a_2016-04-27t10:43:02z0 Hearing Summary

Date: 04/27/2016



Final

BILL SUMMARY for HB16-1324



SENATE COMMITTEE ON AGRICULTURE, NATURAL RESOURCES, & ENERGY


Votes: View--> Action Taken:
Adopt conceptual amendment to amend Page 7 of the

Refer House Bill 16-1324 to the Committee on Appro
Pass Without Objection

PASS







10:43 AM -- HB 16-1324



Senator Sonnenberg, sponsor, described the provisions of House Bill 16-1324 concerning veterinary access to compounded pharmaceutical drugs. Under current law, a veterinarian cannot maintain an office stock of compounded drugs for later distribution or administration to patients. The reengrossed bill allows: a compounding pharmacy that possesses a valid manufacturing registration from the federal Drug Enforcement Administration to compound and distribute a drug to a veterinarian for office use or office stock; a veterinarian to administer to an animal patient a compounded drug maintained for office use; and a veterinarian to dispense to a human client for later administration to an animal patient a compounded drug, maintained as part of the veterinarian's office stock, in an amount not to exceed 5 days' worth of doses, if a patient has an emergency condition that the compounded drug is necessary to treat and the veterinarian cannot access, in a timely manner, the compounded drug through a compounding pharmacy. The Colorado Board of Pharmacy (board) may authorize and license a pharmacy outlet located outside of Colorado to provide compounded veterinary drugs for office use or office stock. Nonresident pharmacy licensees must provide the board with a copy of the most recent state inspection report and information about their state's inspection procedure and criteria for board approval as satisfactorily demonstrating proof of compliance with Colorado regulations. In addition, the nonresident pharmacy must pay for a third-party inspection of its facilities to be submitted to the board. The board may promulgate rules concerning its review of these reports as necessary.



The following persons testified on the bill:



10:45 AM -- Dr. Will French, Colorado Veterinary Medical Association, testified in support of the bill and provided a written statement on the bill (Attachment A) to the committee. Dr. French responded to questions from committee members about limits under current concerning compounded drugs.



160427 AttachA.pdf160427 AttachA.pdf



10:51 AM -- Dr. Randa MacMillan, Colorado Veterinary Medical Association, testified in support of the bill and discussed the activities of small animal veterinarians and the need for compounded drugs.



10:54 AM --
Dr. Bill Fredregill, Colorado Veterinary Medical Association, testified in support of the bill.



10:57 AM --
Sam Romano, Colorado Veterinary Medical Association, testified in support of the bill.



11:01 AM



The chair closed testimony and Senator Sonnenberg closed his remarks on the bill.


BILL: HB16-1324
TIME: 11:00:53 AM
MOVED: Sonnenberg
MOTION: Refer House Bill 16-1324 to the Committee on Appropriations, as amended. The motion passed on a vote of 8-0.
SECONDED:
VOTE
Baumgardner
Yes
Cooke
Yes
Donovan
Yes
Garcia
Excused
Hodge
Yes
Jones
Yes
Scott
Yes
Roberts
Yes
Sonnenberg
Yes
Final YES: 8 NO: 0 EXC: 1 ABS: 0 FINAL ACTION: PASS






BILL: HB16-1324
TIME: 11:01:28 AM
MOVED: Sonnenberg
MOTION: Adopt conceptual amendment to amend Page 7 of the reengrossed bill strike lines 6 through 10 and substitute with an act subject to petition clause. The motion passed without objection.
SECONDED:
VOTE
Baumgardner
Cooke
Donovan
Garcia
Hodge
Jones
Scott
Roberts
Sonnenberg
YES: 0 NO: 0 EXC: 0 ABS: 0 FINAL ACTION: Pass Without Objection











11:04 AM



The committee adjourned.






The House of Representatives and Senate will not convene on Friday, May 29 and Saturday, May 30

COVID-19 Resources

Written Testimony and Witness Sign-up